James Healy - Director at Rapport Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
RAPP on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by James Healy since 4/22/2024

Holdings reported by James Healy for Rapport Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 1.86M $18.6M $9.98 Jul 1, 2024 By Sofinnova Venture Partners XI, L.P.
Common Stock 40.9K $408K $9.98 Jul 1, 2024 By Crestline Summit Master, SPC - PEAK SP
Common Stock 39.7K $396K $9.98 Jul 1, 2024 By CRESTLINE SUMMIT PINNACLE MASTER, L.P.
Common Stock 33.1K $330K $9.98 Jul 1, 2024 By Crestline Summit Master, SPC - CRESTLINE SUMMIT APEX SP
Common Stock 18.6K $186K $9.98 Jul 1, 2024 By Sofinnova Synergy Master Fund LP
Series B Preferred Stock 0 Jun 10, 2024 By Sofinnova Venture Partners XI, L.P. Common Stock

Transactions reported by James Healy for Rapport Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.